Info Meeting: Genetic Contributions to Schizophrenia – A Tale of Thousands of Genes

Featuring: Nora Perrone-Bizzozero, PhD
Prof. of Neurosciences, Psychiatry & Behavioral Sciences UNM
Date: Tuesday, April 9th, 6-7:30 PM
Facebook Live Stream Begins at 6:10 PM

Dr. Nora Perrone-Bizzozero is a Professor of Neurosciences at the University of New Mexico School of Medicine with a secondary appointment in the department of Psychiatry and Behavioral Sciences. Dr. Perrone-Bizzozero was initially trained in Clinical and Basic Biochemistry and Genetics at the University of Buenos Aires, Argentina and later received her post-doctoral training in Neuroscience and Psychiatry at McLean Hospital Harvard Medical School, before joining UNM in 1990.

She is well recognized for her work on the molecular mechanisms controlling the expression of genes during normal brain development and in neurodevelopmental disorders, such as schizophrenia and fetal alcohol exposure, as well as drug addiction.  Dr. Perrone-Bizzozero has received continued federal funding as principal investigator (PI) for the past 28 years and has served a grant reviewer at National Institutes of Health (NIH) study sections for the past 20 years.

For the past 10 years, she has been collaborating with investigators at the Mind Research Network (MRN) studying the effects of gene variation on brain structure and function in patients with schizophrenia; and has been characterizing the molecular mechanisms underlying substance use disorders. She has received several honors including being elected as a fellow of the American Association for the Advancement of Science in 2011. She has published 125 articles, book chapters, and reviews and given lectures on the neurobiological aspects of schizophrenia at national and international meetings. She currently has two grants as PI and is also funded by the New Mexico Alcohol Research Center. Dr. Perrone-Bizzozero is also a member of the faculty development and advisory committee of the MRN/UNM COBRE Phase III center grant on schizophrenia, bipolar disorder and depression.